Serina Therapeutics, Inc. (SER)

Serina Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	54	47	-	-	-
Enterprise Value	47	55	-	-	-
Last Close Price	5.67	5.01	-	-	-
Debt / Equity Ratio	0.91	0.91	0.90	-0.77	1.19
Asset Turnover	0.01	0.01	0.64	0.44	-
Quick Ratio	1.55	1.55	5.39	1.22	3.53
Current Ratio	2.40	2.40	5.39	1.25	3.58
Return on Equity (ROE)	-485.36%	-485.36%	594.25%	-	-
Return on Assets (ROA)	-124.04%	-124.04%	-19.46%	-105.01%	-
Return on Capital (ROIC)	-221.85%	-221.85%	-26.28%	-1390.61%	-
Buyback Yield / Dilution	-83.74%	-83.74%	-86.72%	-0.01%	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q